Research at VIVA

The VIVA Foundation's research program advances the diagnosis, treatment, and overall care of patients with PVD through the design of innovative therapies. Our projects include collaborative partnerships with leading clinical, academic and analytic organizations to ensure comprehensive and rigorous protocols designed to produce compelling, clinically relevant data.

Field-leading advances in vascular disease:

• Patient-Level Meta-Analysis of 999 Claudicants Undergoing Primary Femoropopliteal Nitinol Stent Implantation—Catheterization and Cardiovascular Interventions, 2017

• Carotid Artery Stenting in Asymptomatic Carotid Artery Stenosis—JACC Journal, 2020

• Mortality and Paclitaxel-Coated Devices: An Individual Patient Data Meta-Analysis—Circulation, 2020

• Directional Atherectomy Before Paclitaxel Coated Balloon Angioplasty in Complex Femoropopliteal Disease: The VIVA REALITY Study—Catheterization & Cardiovascular Interventions, 2021

Sponsorship and bridge funding for key trials in the field:

• BEST-CLI (NHLBI)

• BEST Registry (NHLBI)

• REALITY

• XCELL

Developing the next generation of leaders

The VIVA Foundation is proud to offer special funding to support early-career scientists interested in embarking on careers in vascular science, in partnership with the American Heart Association.

Interested parties should visit the AHA Research Partnerships page to learn more, and submit an application for the AHA Postdoctoral Fellowship or Career Development Award. For questions please email apply@heart.org.

Test field